Cargando…

Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders

Small intestinal bacterial overgrowth (SIBO) has been implicated in symptoms associated with functional gastrointestinal disorders (FGIDs), though mechanisms remain poorly defined and treatment involves non-specific antibiotics. Here we show that SIBO based on duodenal aspirate culture reflects an o...

Descripción completa

Detalles Bibliográficos
Autores principales: Saffouri, George B., Shields-Cutler, Robin R., Chen, Jun, Yang, Yi, Lekatz, Heather R., Hale, Vanessa L., Cho, Janice M., Battaglioli, Eric J., Bhattarai, Yogesh, Thompson, Kevin J., Kalari, Krishna K., Behera, Gaurav, Berry, Jonathan C., Peters, Stephanie A., Patel, Robin, Schuetz, Audrey N., Faith, Jeremiah J., Camilleri, Michael, Sonnenburg, Justin L., Farrugia, Gianrico, Swann, Jonathan R., Grover, Madhusudan, Knights, Dan, Kashyap, Purna C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494866/
https://www.ncbi.nlm.nih.gov/pubmed/31043597
http://dx.doi.org/10.1038/s41467-019-09964-7
Descripción
Sumario:Small intestinal bacterial overgrowth (SIBO) has been implicated in symptoms associated with functional gastrointestinal disorders (FGIDs), though mechanisms remain poorly defined and treatment involves non-specific antibiotics. Here we show that SIBO based on duodenal aspirate culture reflects an overgrowth of anaerobes, does not correspond with patient symptoms, and may be a result of dietary preferences. Small intestinal microbial composition, on the other hand, is significantly altered in symptomatic patients and does not correspond with aspirate culture results. In a pilot interventional study we found that switching from a high fiber diet to a low fiber, high simple sugar diet triggered FGID-related symptoms and decreased small intestinal microbial diversity while increasing small intestinal permeability. Our findings demonstrate that characterizing small intestinal microbiomes in patients with gastrointestinal symptoms may allow a more targeted antibacterial or a diet-based approach to treatment.